10 mg rosuvastatin over 4 months with zinc (30 mg/d) supplementation.	10 mg rosuvastatin over 4 months with selenium (150 Î1⁄4g/d) supplementation.	concentrations of zinc and selenium of studied groups.	1673	1823	Neither treatment was associated with significant differences in concentrations of zinc or selenium in blood plasma and erythocytes of studied groups.
10 mg rosuvastatin over 4 months with zinc (30 mg/d) and selenium (150 Î1⁄4g/d) supplementation.	10 mg rosuvastatin over 4 months	glutathione peroxidase (GPx) and superoxide dismutase (SOD) levels	23555	23703	Similarly, the activities of the antioxidant enzymes GPx and SOD were unchanged by treatments (P > 0.42) and were similar in both groups (P > 0.33).
10 mg rosuvastatin over 4 months with zinc (30 mg/d) and selenium (150 Î1⁄4g/d) supplementation.	10 mg rosuvastatin over 4 months	total cholesterol, LDL-c, and non-HDL-c levels	22451	22704	Significant decreases in total cholesterol, LDL-c, and non-HDL-c levels were observed for all patients, regardless of group; however, there were no differences between the rosuvastatin + mineral-supplemented and rosuvastatin + placebo groups (P > 0.21).
10 mg rosuvastatin over 4 months with zinc (30 mg/d) and selenium (150 Î1⁄4g/d) supplementation.	10 mg rosuvastatin over 4 months	Triglycerides concentrations	23028	23248	Triglycerides concentrations dropped noticeably in both groups, though this pattern was significant only for the placebo group (P = 0.034); despite this, differences between the two groups were not significant (P = 0.76)
10 mg rosuvastatin over 4 months with zinc (30 mg/d) supplementation.	10 mg rosuvastatin over 4 months with selenium (150 Î1⁄4g/d) supplementation.	concentrations of zinc and selenium of studied groups.	25013	25215	Neither treatment was associated with significant differences in concentrations of zinc (plasma: P > 0.14; erythrocyte: P > 0.14) or selenium (plasma: P > 0.63; erythrocyte: P > 0.07) of studied groups.
10 mg rosuvastatin over 4 months with zinc (30 mg/d) and selenium (150 Î1⁄4g/d) supplementation.	10 mg rosuvastatin over 4 months	Triglycerides concentrations	23028	23249	Triglycerides concentrations dropped noticeably in both groups, though this pattern was significant only for the placebo group (P = 0.034); despite this, differences between the two groups were not significant (P = 0.76).
10 mg rosuvastatin over 4 months with zinc (30 mg/d) and selenium (150 Î1⁄4g/d) supplementation.	10 mg rosuvastatin over 4 months	glutathione peroxidase (GPx) and superoxide dismutase (SOD) levels	1587	1672	Similarly, the antioxidant enzymes GPx and SOD activity were unchanged by treatments.
